Drug
Ins1202
Ins1202: highest development phase Phase 1, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| INS1202 NCT07290062 | Phase 1 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Ins1202 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.